Ruqaiah Altassan

760 total citations
24 papers, 229 citations indexed

About

Ruqaiah Altassan is a scholar working on Molecular Biology, Genetics and Physiology. According to data from OpenAlex, Ruqaiah Altassan has authored 24 papers receiving a total of 229 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Genetics and 6 papers in Physiology. Recurrent topics in Ruqaiah Altassan's work include Glycosylation and Glycoproteins Research (7 papers), Genetics and Neurodevelopmental Disorders (5 papers) and Neonatal Health and Biochemistry (4 papers). Ruqaiah Altassan is often cited by papers focused on Glycosylation and Glycoproteins Research (7 papers), Genetics and Neurodevelopmental Disorders (5 papers) and Neonatal Health and Biochemistry (4 papers). Ruqaiah Altassan collaborates with scholars based in Saudi Arabia, United States and Belgium. Ruqaiah Altassan's co-authors include Jaak Jaeken, Éva Morava, Mohammed Al‐Owain, Peter Witters, David Cassiman, Wafaa Eyaid, Sulaiman M. Al‐Mayouf, Rita Francisco, Dorinda Marques‐da‐Silva and Paula A. Videira and has published in prestigious journals such as Genetics in Medicine, Journal of Clinical Medicine and Molecular Genetics and Metabolism.

In The Last Decade

Ruqaiah Altassan

23 papers receiving 228 citations

Peers

Ruqaiah Altassan
Arum Oh South Korea
Omid Omrani Germany
Miski Mohamed Netherlands
Patroula Smpokou United States
Ruqaiah Altassan
Citations per year, relative to Ruqaiah Altassan Ruqaiah Altassan (= 1×) peers Patryk Lipiński

Countries citing papers authored by Ruqaiah Altassan

Since Specialization
Citations

This map shows the geographic impact of Ruqaiah Altassan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruqaiah Altassan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruqaiah Altassan more than expected).

Fields of papers citing papers by Ruqaiah Altassan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruqaiah Altassan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruqaiah Altassan. The network helps show where Ruqaiah Altassan may publish in the future.

Co-authorship network of co-authors of Ruqaiah Altassan

This figure shows the co-authorship network connecting the top 25 collaborators of Ruqaiah Altassan. A scholar is included among the top collaborators of Ruqaiah Altassan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruqaiah Altassan. Ruqaiah Altassan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eklund, Erik A., Silvia Radenkovic, Bobby G. Ng, et al.. (2024). ALG13-Congenital Disorder of Glycosylation (ALG13-CDG): Updated clinical and molecular review and clinical management guidelines. Molecular Genetics and Metabolism. 142(2). 108472–108472. 1 indexed citations
2.
Muthusamy, Karthik, Judit Perez Ortiz, Anna N. Ligezka, et al.. (2023). Neurological manifestations in PMM2-congenital disorders of glycosylation (PMM2-CDG): Insights into clinico-radiological characteristics, recommendations for follow-up, and future directions. Genetics in Medicine. 26(2). 101027–101027. 6 indexed citations
3.
Altassan, Ruqaiah, et al.. (2023). Defining the phenotype of PGAP3-congenital disorder of glycosylation; a review of 65 cases. Molecular Genetics and Metabolism. 140(3). 107688–107688. 1 indexed citations
4.
Balakrishnan, Bijina, Ruqaiah Altassan, Willisa Liou, et al.. (2023). AAV-based gene therapy prevents and halts the progression of dilated cardiomyopathy in a mouse model of phosphoglucomutase 1 deficiency (PGM1-CDG). Translational research. 257. 1–14. 12 indexed citations
5.
Altassan, Ruqaiah, Hindi Al‐Hindi, Hazem Ghebeh, et al.. (2023). Expanding the phenotypic and genotypic spectrum of GGPS1 related congenital muscular dystrophy. American Journal of Medical Genetics Part A. 194(4). e63498–e63498.
6.
Altassan, Ruqaiah, Riyadh Alokaili, Khalid Alhasan, et al.. (2022). Further delineation of GEMIN4 related neurodevelopmental disorder with microcephaly, cataract, and renal abnormalities syndrome. American Journal of Medical Genetics Part A. 188(10). 2932–2940. 1 indexed citations
7.
Altassan, Ruqaiah, Dimpna C. Albert, Mohammad Al-Owain, et al.. (2022). Successful heart transplantation in an infant with phosphoglucomutase 1 deficiency (PGM1‐CDG). JIMD Reports. 64(2). 123–128. 3 indexed citations
8.
Altassan, Ruqaiah, Raashda A. Sulaiman, Zuhair N. Al‐Hassnan, et al.. (2022). COVID-19 in Unvaccinated patients with inherited metabolic disorders: A single center experience. European Journal of Medical Genetics. 65(11). 104602–104602. 1 indexed citations
9.
Francisco, Rita, Carlota Pascoal, Dorinda Marques‐da‐Silva, et al.. (2020). New Insights into Immunological Involvement in Congenital Disorders of Glycosylation (CDG) from a People-Centric Approach. Journal of Clinical Medicine. 9(7). 2092–2092. 25 indexed citations
10.
Bird, Matthew, Petra Windmolders, Ingrid Vander Elst, et al.. (2019). Oxygraphy Versus Enzymology for the Biochemical Diagnosis of Primary Mitochondrial Disease. Metabolites. 9(10). 220–220. 4 indexed citations
11.
Moravej, Hossein, Ruqaiah Altassan, Jaak Jaeken, et al.. (2019). Hypoglycemia in CDG patients due to PMM2 mutations: Follow up on hyperinsulinemic patients. JIMD Reports. 51(1). 76–81. 10 indexed citations
12.
Altassan, Ruqaiah, Dalal Bubshait, Faiqa Imtiaz, & Zuhair Rahbeeni. (2018). A retrospective biochemical, molecular, and neurocognitive review of Saudi patients with argininosuccinic aciduria. European Journal of Medical Genetics. 61(6). 307–311. 4 indexed citations
13.
Williams, Monique, Vassili Valayannopoulos, Ruqaiah Altassan, et al.. (2018). Clinical, biochemical, and molecular overview of transaldolase deficiency and evaluation of the endocrine function: update of 34 patients. Journal of Inherited Metabolic Disease. 2 indexed citations
14.
Witters, Peter, Tomáš Honzík, Ruqaiah Altassan, et al.. (2018). Long-term follow-up in PMM2-CDG: are we ready to start treatment trials?. Genetics in Medicine. 21(5). 1181–1188. 35 indexed citations
15.
Altassan, Ruqaiah, Stéphanie Fox, Chantal Poulin, & Daniela Buhaş. (2018). Hyperphosphatasia with mental retardation syndrome, expanded phenotype of PIGL related disorders. Molecular Genetics and Metabolism Reports. 15. 46–49. 13 indexed citations
16.
Ben‐Omran, Tawfeg, Khushnooda Ramzan, Ruqaiah Altassan, et al.. (2018). Delineating the phenotypic spectrum of hyperphosphatasia with mental retardation syndrome 4 in 14 patients of Middle‐Eastern origin. American Journal of Medical Genetics Part A. 176(12). 2850–2857. 5 indexed citations
17.
Altassan, Ruqaiah, Tariq Masoodi, Ola Khalifa, et al.. (2017). Exome sequencing identifies novel NTRK1 mutations in patients with HSAN‐IV phenotype. American Journal of Medical Genetics Part A. 173(4). 1009–1016. 15 indexed citations
18.
Altassan, Ruqaiah, Peter Witters, Zubaida Saifudeen, et al.. (2017). Renal involvement in PMM2-CDG, a mini-review. Molecular Genetics and Metabolism. 123(3). 292–296. 18 indexed citations
19.
Shaheen, Ranad, Mohammed Al‐Owain, Maha S. Zaki, et al.. (2013). Identification of three novel ECEL1 mutations in three families with distal arthrogryposis type 5D. Clinical Genetics. 85(6). 568–572. 21 indexed citations
20.
Eyaid, Wafaa, et al.. (2012). Intracranial calcifications, microcephaly, and seizure. If not congenital infection, what could it be?. PubMed. 17(3). 248–52. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026